Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathias Jachs

Showing results (31-40 of 118) with videos related to

Pageof 12
Sort By:
Scientific Reports|January 18, 2023
The systemic and hepatic alternative renin-angiotensin system is activated in liver cirrhosis, linked to endothelial dysfunction and inflammationLukas Hartl, Benedikt Rumpf, Oliver Domenig, et al.
Journal of Hepatology|October 19, 2020
Systemic inflammation increases across distinct stages of advanced chronic liver disease and correlates with decompensation and mortalityDalila Costa, Benedikt Simbrunner, Mathias Jachs, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 13, 2021
Decreasing von Willebrand Factor Levels Upon Nonselective Beta Blocker Therapy Indicate a Decreased Risk of Further Decompensation, Acute-on-chronic Liver Failure, and DeathMathias Jachs, Lukas Hartl, Benedikt Simbrunner, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 16, 2022
The Sequential Application of Baveno VII Criteria and VITRO Score Improves Diagnosis of Clinically Significant Portal HypertensionMathias Jachs, Lukas Hartl, Benedikt Simbrunner, et al.
Journal of Hepatology|January 13, 2024
Prognostic performance of non-invasive tests for portal hypertension is comparable to that of hepatic venous pressure gradientMathias Jachs, Lukas Hartl, Benedikt Simbrunner, et al.
United European Gastroenterology Journal|May 29, 2021
Patterns of acute decompensation in hospitalized patients with cirrhosis and course of acute-on-chronic liver failureLorenz Balcar, Georg Semmler, Katharina Pomej, et al.
JHEP Reports : Innovation in Hepatology|July 24, 2023
An impaired pituitary-adrenal signalling axis in stable cirrhosis is linked to worse prognosisLukas Hartl, Benedikt Simbrunner, Mathias Jachs, et al.
Wiener Klinische Wochenschrift|June 28, 2021
Outcomes of an HCV elimination program targeting the Viennese MSM populationMathias Jachs, Teresa Binter, David Chromy, et al.
United European Gastroenterology Journal|March 25, 2023
Eligibility for antiviral therapy and treatment uptake in chronic hepatitis B patients referred to a European tertiary care centerMathias Jachs, Raphael Sauberer, Alexander Stiegler, et al.
JHEP Reports : Innovation in Hepatology|June 26, 2023
Long-term follow-up of patients discontinuing bulevirtide treatment upon long-term HDV-RNA suppressionMathias Jachs, Marlene Panzer, Lukas Hartl, et al.
Pageof 12

Showing results (31-40 of 118) with videos related to

Sort By:
Pageof 12
Scientific Reports|January 18, 2023
The systemic and hepatic alternative renin-angiotensin system is activated in liver cirrhosis, linked to endothelial dysfunction and inflammationLukas Hartl, Benedikt Rumpf, Oliver Domenig, et al.
Journal of Hepatology|October 19, 2020
Systemic inflammation increases across distinct stages of advanced chronic liver disease and correlates with decompensation and mortalityDalila Costa, Benedikt Simbrunner, Mathias Jachs, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 13, 2021
Decreasing von Willebrand Factor Levels Upon Nonselective Beta Blocker Therapy Indicate a Decreased Risk of Further Decompensation, Acute-on-chronic Liver Failure, and DeathMathias Jachs, Lukas Hartl, Benedikt Simbrunner, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 16, 2022
The Sequential Application of Baveno VII Criteria and VITRO Score Improves Diagnosis of Clinically Significant Portal HypertensionMathias Jachs, Lukas Hartl, Benedikt Simbrunner, et al.
Journal of Hepatology|January 13, 2024
Prognostic performance of non-invasive tests for portal hypertension is comparable to that of hepatic venous pressure gradientMathias Jachs, Lukas Hartl, Benedikt Simbrunner, et al.
United European Gastroenterology Journal|May 29, 2021
Patterns of acute decompensation in hospitalized patients with cirrhosis and course of acute-on-chronic liver failureLorenz Balcar, Georg Semmler, Katharina Pomej, et al.
JHEP Reports : Innovation in Hepatology|July 24, 2023
An impaired pituitary-adrenal signalling axis in stable cirrhosis is linked to worse prognosisLukas Hartl, Benedikt Simbrunner, Mathias Jachs, et al.
Wiener Klinische Wochenschrift|June 28, 2021
Outcomes of an HCV elimination program targeting the Viennese MSM populationMathias Jachs, Teresa Binter, David Chromy, et al.
United European Gastroenterology Journal|March 25, 2023
Eligibility for antiviral therapy and treatment uptake in chronic hepatitis B patients referred to a European tertiary care centerMathias Jachs, Raphael Sauberer, Alexander Stiegler, et al.
JHEP Reports : Innovation in Hepatology|June 26, 2023
Long-term follow-up of patients discontinuing bulevirtide treatment upon long-term HDV-RNA suppressionMathias Jachs, Marlene Panzer, Lukas Hartl, et al.
Pageof 12